CTCBIO Inc. (KOSDAQ:060590)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,120.00
-50.00 (-0.97%)
At close: Dec 5, 2025
-23.47%
Market Cap 122.41B
Revenue (ttm) 132.76B
Net Income (ttm) 2.64B
Shares Out 23.91M
EPS (ttm) 98.59
PE Ratio 51.77
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 39,425
Average Volume 67,106
Open 5,170.00
Previous Close 5,170.00
Day's Range 5,060.00 - 5,200.00
52-Week Range 4,765.00 - 7,910.00
Beta -0.08
RSI 46.71
Earnings Date Nov 12, 2025

About CTCBIO

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC cov... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1993
Employees 248
Stock Exchange KOSDAQ
Ticker Symbol 060590
Full Company Profile

Financial Performance

In 2024, CTCBIO's revenue was 144.41 billion, an increase of 4.74% compared to the previous year's 137.88 billion. Losses were -5.22 billion, -66.51% less than in 2023.

Financial Statements

News

There is no news available yet.